A carregar...

Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women

For more than 20 years, tamoxifen has been the gold standard for the adjuvant treatment of postmenopausal women with hormone-responsive early breast cancer. However, recent randomized trials have shown efficacy and tolerability benefits with the third-generation aromatase inhibitor anastrozole, resu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gangadhara, Sharath, Bertelli, Gianfilippo
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2690973/
https://ncbi.nlm.nih.gov/pubmed/19753124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!